These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9069580

  • 21. The crystal structure of pertussis toxin.
    Stein PE, Boodhoo A, Armstrong GD, Cockle SA, Klein MH, Read RJ.
    Structure; 1994 Jan 15; 2(1):45-57. PubMed ID: 8075982
    [Abstract] [Full Text] [Related]

  • 22. Role of carbohydrate recognition domains of pertussis toxin in adherence of Bordetella pertussis to human macrophages.
    van't Wout J, Burnette WN, Mar VL, Rozdzinski E, Wright SD, Tuomanen EI.
    Infect Immun; 1992 Aug 15; 60(8):3303-8. PubMed ID: 1353482
    [Abstract] [Full Text] [Related]

  • 23. Bacterial agents protect against autoimmune disease. I. Mice pre-exposed to Bordetella pertussis or Mycobacterium tuberculosis are highly refractory to induction of experimental autoimmune encephalomyelitis.
    Lehmann D, Ben-Nun A.
    J Autoimmun; 1992 Dec 15; 5(6):675-90. PubMed ID: 1489483
    [Abstract] [Full Text] [Related]

  • 24. Preliminary X-ray crystallographic analysis of holotoxin from Bordetella pertussis.
    Raghavan M, Gotto JW, Scott JV, Schutt CE.
    J Mol Biol; 1990 Jun 05; 213(3):411-4. PubMed ID: 2352276
    [Abstract] [Full Text] [Related]

  • 25. Acellular pertussis vaccines: neutralization by immune sera of the lethality of pertussis toxin and viable Bordetella pertussis for chick embryos.
    Calver GA.
    Biologicals; 1999 Jun 05; 27(2):143-7. PubMed ID: 10600203
    [Abstract] [Full Text] [Related]

  • 26. The subunit S1 is important for pertussis toxin secretion.
    Pizza M, Bugnoli M, Manetti R, Covacci A, Rappuoli R.
    J Biol Chem; 1990 Oct 15; 265(29):17759-63. PubMed ID: 2211659
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Site-specific alterations in the B oligomer that affect receptor-binding activities and mitogenicity of pertussis toxin.
    Lobet Y, Feron C, Dequesne G, Simoen E, Hauser P, Locht C.
    J Exp Med; 1993 Jan 01; 177(1):79-87. PubMed ID: 8418210
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment.
    Silver PB, Chan CC, Wiggert B, Caspi RR.
    Invest Ophthalmol Vis Sci; 1999 Nov 01; 40(12):2898-905. PubMed ID: 10549650
    [Abstract] [Full Text] [Related]

  • 31. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine.
    Isaka M, Komiya T, Takahashi M, Yasuda Y, Taniguchi T, Zhao Y, Matano K, Matsui H, Maeyama J, Morokuma K, Ohkuma K, Goto N, Tochikubo K.
    Vaccine; 2004 Aug 13; 22(23-24):3061-8. PubMed ID: 15297056
    [Abstract] [Full Text] [Related]

  • 32. Pertussis toxin and the adenylate cyclase toxin from Bordetella pertussis activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cAMP-dependent pathway.
    Bagley KC, Abdelwahab SF, Tuskan RG, Fouts TR, Lewis GK.
    J Leukoc Biol; 2002 Nov 13; 72(5):962-9. PubMed ID: 12429718
    [Abstract] [Full Text] [Related]

  • 33. [Experimental relation between histamine-sensitizing factor and the protective antigen of Bordetella pertussis].
    Jiménez Paredes J, Ruiz Puente J, González Pacheco M.
    Salud Publica Mex; 1981 Nov 13; 23(6):621-9. PubMed ID: 6278660
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Expression of a synthetic pertussis toxin operon in Escherichia coli.
    Pozza TD, Yan H, Walker MJ.
    Vaccine; 1997 Jun 13; 15(9):968-75. PubMed ID: 9261943
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Properties of the B oligomer of pertussis toxin.
    Nencioni L, Pizza MG, Volpini G, De Magistris MT, Giovannoni F, Rappuoli R.
    Infect Immun; 1991 Dec 13; 59(12):4732-4. PubMed ID: 1937835
    [Abstract] [Full Text] [Related]

  • 38. Identification of linear B-cell determinants of pertussis toxin associated with the receptor recognition site of the S3 subunit.
    Schmidt MA, Raupach B, Szulczynski M, Marzillier J.
    Infect Immun; 1991 Apr 13; 59(4):1402-8. PubMed ID: 1706321
    [Abstract] [Full Text] [Related]

  • 39. The role of the S-1 and B-oligomer components of pertussis toxin in its adjuvant properties for Th1 and Th2 cells.
    Ryan MS, Griffin F, Mahon B, Mills KH.
    Biochem Soc Trans; 1997 Feb 13; 25(1):126S. PubMed ID: 9057024
    [No Abstract] [Full Text] [Related]

  • 40. Properties of pertussis toxin B oligomer assembled in vitro from recombinant polypeptides produced by Escherichia coli.
    Burnette WN, Arciniega JL, Mar VL, Burns DL.
    Infect Immun; 1992 Jun 13; 60(6):2252-6. PubMed ID: 1587592
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.